Tradestie Institutional Equity Comparison Engine

QNRX vs VRAX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VRAX Overall Edge

VRAX Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Virax Biolabs Group Limited Ordinary Shares (VRAX) driven by superior Growth & Margin, Momentum & Technical while QNRX counters with relative strength in Valuation. Fundamentally, QNRX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus VRAX at N/M Forward P/E and -51515.2% operating margin (+684.9% YoY). In options structure, QNRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against VRAX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner QNRX
QNRX N/M vs VRAX N/M Fwd P/E
Growth & Margin Winner VRAX
Op Margin 0.0% vs -51515.2% ยท YoY +0.0% vs +684.9%
Momentum & Technical Winner VRAX
1Y -82.0% vs -24.6% ยท 52W Pos 0% vs 2%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
QNRX NASDAQ
Quoin Pharmaceuticals, Ltd. American Depositary Shares
Pharmaceutical Preparations
$3.28
-2.35% 1D
Market Cap $16.1M
1M Return -18.2%
1Y Return -81.96%
Forward P/E N/M
Unified AI Score
46.1 / 100 HOLD
Tech 38.0 Fund 47.0 Flow 50.0 Mom 64.0
VRAX NASDAQ
Virax Biolabs Group Limited Ordinary Shares
In Vitro & In Vivo Diagnostic Substances
$0.33
-12.89% 1D
Market Cap $470,745
1M Return -73.13%
1Y Return -24.62%
Forward P/E N/M
Unified AI Score
46.5 / 100 HOLD
Tech 45.0 Fund 50.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: QNRX -81.96% VRAX -24.62% Spread: +57.34 pp (VRAX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
QNRX TTM Op. Margin: 0.0% VRAX TTM Op. Margin: -51515.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on QNRX vs VRAX. Trailing 12-month operating profitability (QNRX 0.0% vs VRAX -51515.2%) and valuation multiples (QNRX N/M vs VRAX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: QNRX (4) vs VRAX (4)
Institutional Metric QNRX VRAX Criterion Row Winner
Market Capitalization Scale $16.1M $470,745 Larger Scale QNRX
Trailing P/E Ratio Valuation 7.6x N/M Lower Multiple QNRX
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +684.9% Higher Growth VRAX
Operating Margin (TTM) Profitability 0.0% -51515.2% Higher Margin QNRX
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -142.6% -78.6% Higher ROE VRAX
52-Week Range Position Momentum 0% ($3โ€“$24) 2% ($0โ€“$13) Stronger Trend VRAX
Beta / 30D Volatility Risk Regime 1.34ฮฒ ยท 74% Vol -8.20ฮฒ ยท 162% Vol Lower Realized Risk QNRX
Unified Institutional Score Composite Signal 46.1 / 100 (HOLD) 46.5 / 100 (HOLD) Higher Composite VRAX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full QNRX vs VRAX Buy Guide
QNRX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live QNRX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VRAX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VRAX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither QNRX nor VRAX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.